Keywords
Affiliated Institutions
Related Publications
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events...
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y<sub>12</sub> inhibitor, an antithrombotic regimen that included apixaban, wit...
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
As compared with aspirin alone and a combination of aspirin and warfarin, treatment with aspirin and ticlopidine resulted in a lower rate of stent thrombosis, although there wer...
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention
Background— Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention...
Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose
Background— Clopidogrel loading has mostly been studied in clopidogrel-naïve patients. Whether clopidogrel-treated patients readmitted for an acute coronary syndrome or percuta...
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 41
- Issue
- 4
- Pages
- S79-S88
- Citations
- 97
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1016/s0735-1097(02)02831-0